|
HS Code |
227726 |
| Generic Name | Levosulpiride |
| Drug Class | Atypical antipsychotic and prokinetic agent |
| Mechanism Of Action | Selective antagonist of dopamine D2 receptors |
| Indications | Dyspepsia, irritable bowel syndrome, gastroparesis, depression, schizophrenia |
| Route Of Administration | Oral and intramuscular |
| Bioavailability | 30-50% |
| Half Life | 6-8 hours |
| Common Side Effects | Drowsiness, fatigue, increased prolactin, weight gain, extrapyramidal symptoms |
| Contraindications | Pheochromocytoma, epilepsy, manic states, hypersensitivity |
| Metabolism | Minimal hepatic metabolism |
| Excretion | Primarily renal |
| Molecular Formula | C15H23N3O4S |
| Brand Names | Neopride, Levopraid, Lesuride |
As an accredited Levosulpiride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white rectangular box labeled "Levosulpiride 25 mg," containing 10 tablets in blister packs, with dosage and manufacturer details displayed. |
| Shipping | Levosulpiride is shipped in compliance with international chemical transport regulations. It is packaged securely in airtight, tamper-evident containers, clearly labeled for pharmaceutical use. During transit, it is protected from moisture, light, and extreme temperatures to ensure product stability and safety. Accompanying documentation ensures traceability and regulatory compliance. |
| Storage | Levosulpiride should be stored in a tightly closed container at room temperature, ideally between 20°C to 25°C (68°F to 77°F). It must be kept away from moisture, direct sunlight, and sources of heat. The storage area should be dry, well-ventilated, and inaccessible to children and pets. Avoid storing it in the bathroom or near chemicals with strong odors. |
|
Purity 99%: Levosulpiride Purity 99% is used in pharmaceutical formulations for gastrointestinal disorders, where enhanced drug efficacy and patient compliance are achieved due to high active content. Molecular Weight 341.43 g/mol: Levosulpiride Molecular Weight 341.43 g/mol is utilized in oral dosage forms targeting dyspepsia, where predictable pharmacokinetic profiles improve therapeutic outcomes. Melting Point 178°C: Levosulpiride Melting Point 178°C is used in tablet manufacturing, where thermal stability supports consistent product quality during production processes. Particle Size <10 μm: Levosulpiride Particle Size <10 μm is incorporated in suspension formulations for pediatric patients, where rapid dispersion and absorption are obtained. Stability Temperature up to 40°C: Levosulpiride Stability Temperature up to 40°C is employed in extended shelf-life medicinal products, where effective storage under varied conditions is ensured. |
Competitive Levosulpiride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Levosulpiride is one of those medicines that has quietly transformed how doctors address problems linked to the gut and the mind. Originally developed as a selective dopamine D2 receptor antagonist, it came onto the scene as part of the benzamide group of drugs. Unlike the older, more sedating antipsychotic medicines, Levosulpiride brings its own personality—some people feel a great sense of relief after being prescribed this treatment for long-standing digestive issues and certain mental health concerns. I have seen family members and patients struggle with symptoms of functional dyspepsia, the kind of unrelenting discomfort that puts a damper on daily life. Levosulpiride entered the picture as a solid option when other medicines had lost their shine or caused too many side effects.
The drug’s profile stands out because it works both on the brain and the gut. Most of the dopamine in the body doesn't sit in our heads; surprising as it sounds, a big chunk works inside the digestive tract, especially in regulating motility and sensation. Levosulpiride passes through the blood-brain barrier, but, in practice, it is often described as “peripherally selective,” meaning its action on the gut takes center stage. The difference becomes more noticeable when you compare it to older drugs like metoclopramide and traditional neuroleptics. I remember reading about patients using metoclopramide who faced a risk of tiring neurological side effects after a few weeks. Levosulpiride holds its own by appearing to show a better side effect profile, particularly for movement disorders, when used for digestive conditions and in low doses.
Unlike antipsychotics that tend to make people sleepy or weigh them down with feelings of dullness, Levosulpiride’s approach means patients often report feeling clear-headed and engaged. In terms of structure, its molecular model gives it a high degree of selectivity, letting it mostly target the dopamine D2 receptors without stirring up unwanted turmoil in other neurotransmitter systems. For those of us intrigued by the science, this selectivity means fewer surprises in the form of off-target effects.
Inside the doctor’s office, Levosulpiride commonly finds its place in prescriptions for functional gastrointestinal disorders. Functional dyspepsia, which shows up as a nagging upper belly discomfort or a feeling of fullness, often drives people to look for answers. In my own practice, I have come across many who’ve seen little improvement after trying antacids, dietary changes, and other stomach-settling medicines. Levosulpiride is taken orally—usually as 25 mg to 75 mg doses, although doctors tailor the exact amount per individual—and offers relief for that sense of persistent stomach unease.
What sets Levosulpiride apart from antacids or simple prokinetic drugs like domperidone is its dual action: it soothes symptoms like nausea, bloating, and upper abdominal pain by improving gut motility and simultaneously modulating signals in the nervous system that contribute to discomfort. One thing I keep in mind: not every patient benefits or tolerates the same drug in the same way. The evidence, gathered from real clinic notes and from randomized controlled studies, shows about half the people treated see noticeable relief in weeks, even after trying and failing with other options.
Levosulpiride has a foot in psychiatry’s door too. Originally, benzamide derivatives were looked at for their effect on mental health; Levosulpiride fits within this class, but its effect is milder in the psychiatric realm than its “cousins” like sulpiride. For doctors treating mild-to-moderate depressive states and certain anxiety disorders, Levosulpiride can help without dragging down a person’s sense of energy. Several studies have looked at its role in dysthymia and somatoform disorders—people whose minds and bodies seem to miscommunicate, leading to chronic physical complaints that stem from deeper emotional struggles.
It can be challenging to find a medicine that supports mental well-being without unwanted sedation or weight gain. Here, too, Levosulpiride steps forward. By blocking central dopamine D2 receptors in certain brain pathways, it lifts mood and relieves mild psychomotor symptoms, all while staying clear of some of the harsher impacts seen in more potent antipsychotics. That said, no drug is risk-free or a silver bullet. Clinicians watch for symptoms like elevated prolactin, which can cause issues in some, especially with long-term use. Knowing these risks and adjusting use accordingly makes all the difference.
Every treatment arsenal includes many tools, and Levosulpiride stands apart by straddling two fields—gastroenterology and psychiatry. Doctors once relied almost exclusively on drugs like metoclopramide, domperidone, or classical antipsychotics. These medications come with their own baggage. Metoclopramide, an older stomach prokinetic, often brings up movement disorder risks when used too long, which can be disheartening for patients relieved from GI symptoms but facing tremors or restlessness. Domperidone, blocked from passing into the brain, tends to have fewer central side effects but also misses out on helping conditions with a psychological component.
Levosulpiride offers a middle road. It addresses both the gut and mind, but with a lighter touch on complications. For older adults or people sensitive to drowsiness and confusion, this difference matters a lot. Other options commonly target just one part of the problem—either offering GI motility support without mental health impact, or targeting mental health at the cost of gut function or tolerability.
Unlike anticholinergic-heavy psychiatric drugs, Levosulpiride avoids worsening constipation or causing dry mouth. For patients already anxious about side effects or juggling multiple medications, the risk-benefit tradeoff often falls in Levosulpiride’s favor after careful discussion.
Most Levosulpiride given today arrives as an oral tablet, generally available in strengths like 25 mg and 50 mg. A doctor will fine-tune the dose depending on whether the goal centers on gut symptoms or mixed psychological complaints. For those with swallowing concerns, some brands produce dispersible or liquid formulations; practical for older patients or those with trouble taking pills.
In terms of specifications, pharmaceutical standards stick to purity and quality requirements, with manufacturers ensuring each batch of Levosulpiride meets pharmacopoeial norms for identity and stability. From my experience, most patients tolerate the tablets well when taken with or just before meals—a common instruction that prevents stomach upset and supports absorption. There’s a growing body of research on modified-release versions and combinations with other drugs like proton pump inhibitors, designed to address tough-to-treat GI symptoms.
Every medication can trigger side effects, and Levosulpiride is no exception. Key concerns include symptoms that come with slightly higher prolactin levels: in women, this could bring about menstrual cycle changes; for men, breast tenderness or mild galactorrhea is possible, though it often resolves after stopping the drug. Central nervous system side effects—such as restlessness, drowsiness, or rare movement disorders—turn up mostly at much higher doses or with very long-term use.
I always remind people that careful monitoring helps put risk in context. For many with moderate GI symptoms or early psychiatric complaints, short-term or cyclical use sharply reduces these concerns. Drug interactions don’t show up as often as with some other medicines, but combining Levosulpiride with strong dopamine antagonists or other antipsychotic drugs calls for extra caution. Blood pressure changes and heart rhythm concerns rarely surface, but considering these aspects sets apart a well-managed treatment plan from a reckless one.
Patients using Levosulpiride often share that it brings a sense of normalcy back to daily life, especially where unexplained stomach discomfort or chronic mild mood changes had disrupted routines. People on long work commutes, for instance, find that fewer bouts of nausea or stomach ache means more time focusing or socializing, not hunting for restrooms or reaching for over-the-counter fixes.
A recurring experience is the gradual, often subtle improvement—less grumbling, less bloating, a feeling that the gut "settles" over a couple of weeks. Mental clarity also often gets a boost in select patients using it for mood or gentle anxiety complaints, leading to better productivity and an improved outlook. Of course, not every story is the same. A few discontinue because of side effects, but for many, it becomes a steady companion in their regimen, chosen for a mix of effectiveness and lower perceived risk compared to alternatives.
People reaching out to gastroenterologists frequently ask for “something different” or something “that works where everything else fails.” These sentiments echo what Levosulpiride offers—a tried and tested option when digestive and psychological complaints overlap or defy common treatments.
Questions often arise about how long to use Levosulpiride, when to stop, and how to switch away if it does not help. Best practices tend to favor starting at the lowest dose that brings benefit, with clear goals in mind—symptom reduction, mood improvement, or both. Doctors review progress regularly, especially for women of child-bearing age or those with a history of hormonal imbalances. Monitoring for prolactin changes forms part of the conversation, as does planning a gradual taper for people using the medicine for longer spans.
Doctors balance the short-term relief Levosulpiride offers with a long-range view of a patient’s health. Specialized attention pays off: in older adults, those with a history of neuroleptic sensitivity, or anyone juggling medicines known to affect the heart or hormone levels, Levosulpiride becomes a carefully weighed choice. A few professional guidelines suggest intermittent use or limiting course length, especially in non-psychiatric indications, reducing the risk of side effects building up over time.
Responsible prescribing makes all the difference. Setting expectations matter—patients do better when they know what to watch for. I see value in upfront conversations: discussing risks, explaining signs of side effects, and planning check-ins. For GI complaints, pairing Levosulpiride with tailored lifestyle changes (better sleep, mindful eating, routine exercise) often brings the best results.
In some cases, doctors pair Levosulpiride with other medications to address root causes—a common tactic in tough-to-treat dyspepsia or mixed anxiety states. Understanding each person’s medical history, especially regarding mental health or past problems with dopamine-blocking drugs, shapes the safest route.
Better record-keeping and communication between hospitals, pharmacies, and primary care allows for swift recognition of side effects and careful adjustment of dosing. Incorporating blood tests for prolactin or routine symptom surveys means fewer surprises. Many hospitals now train clinicians to recognize subtle neurological symptoms early, reducing the risk for patients vulnerable to even rare reactions.
Digital health tools, like automated reminders or patient portals, support regular follow-up and encourage honest reporting of new symptoms—not just relying on rushed in-person consults. As virtual care expands, Levosulpiride fits well into protocols for remote symptom tracking, letting more people access timely assistance or dose adjustments as needed.
In countries where functional GI disorders are common and resources may be stretched, medicines like Levosulpiride play an even greater role. Treatment gaps due to stigma or lack of awareness mean many suffer longer than needed. Educational outreach—direct to patients and through community physicians—focuses on the link between gut and mind, simplifying complex science into practical advice.
For people living with chronic, unexplained stomach complaints, the right medication can be a lifeline. As more data emerges from long-term studies and local observational research, we get sharper insights into who benefits the most and how to minimize risk. Specialty societies encourage ongoing physician education, keeping clinicians up-to-date with the latest recommendations and real-world feedback.
Newer research also looks at how Levosulpiride might fit in with comprehensive mental health care approaches. In out-patient psychiatric clinics, people with anxiety or mild depression sometimes find relief without facing the common sedative side effects of other therapies.
The story of Levosulpiride continues to be written. Its dual impact across digestive and mental health makes it a mainstay in clinics facing these overlapping complaints. For many, this medicine delivers meaningful symptom relief while returning a degree of freedom lost to illness. As science and care standards progress, Levosulpiride remains both a reliable and adaptable tool, shaped by real-world experience, guided by careful prescribing, and supported by an approach that values the whole patient.
Practical experience offers perspective beyond the results of clinical trials. The reasons people seek out Levosulpiride often stem from frustration—persistent symptoms that drain quality of life, missed opportunities for joy, and the desire to regain a sense of control. I hear from patients who want to avoid a tradeoff between gut and mind, seeking dignity in both areas without more pills on the nightstand than necessary. Doctors familiar with Levosulpiride appreciate the relatively clean side effect record at moderate doses, the flexibility in dosing schedules, and options to combine with other supportive measures for a more balanced outcome.
Knowledge grows as more voices join the conversation. Patients and practitioners alike shape the evolving reputation of Levosulpiride—not just as a name on a prescription slip, but as an option forged from listening, learning, and responding to needs that are as human as they are complex.